Compare HSBC Holdings plc (HSBC) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HSBC Holdings plc vs Novavax Inc — how do they compare? HSBC Holdings plc trades at $104.11 (market cap $353.82B), while Novavax Inc trades at $7.94 (market cap $1.31B). The key difference: HSBC Holdings plc is far larger — about 270.1× Novavax Inc's market cap, and HSBC Holdings plc pays a 3.63% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| HSBC | NVAX | |
|---|---|---|
Market Cap | $353.82B | $1.31B |
Sector | Technology | Health |
52-Week High | $107.86 | $11.19 |
52-Week Low | $63.84 | $6.22 |
Dividend Yield | 3.63% | — |
Enterprise Value | — | $889.30M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HSBC trades at $104.05, up 0.71% today, with a bullish technical signal from moving averages and a P/E of 14.74. The bank reported strong Q2 2026 results, including a 7% revenue increase and a $1 billion buyback, while maintaining a 34.54% net income margin. Recent news highlights leadership changes and China-related market pressures.
Outlook remains positive due to earnings momentum and shareholder returns, but risks include China regulatory shifts and valuation concerns after a 40% run. Analyst consensus is mixed with 38% buy ratings, suggesting cautious optimism amid growth and external headwinds.
NVAX trades at $7.95, up 0.76% on the day, with a bullish technical signal despite mixed indicators. The company reported a net income of $440.30M for 2025, a significant turnaround from prior losses, and has beaten earnings estimates for three consecutive quarters. Recent news highlights Q2 2026 results and a raised revenue outlook, driven by licensing milestones with Sanofi.
The outlook is cautiously optimistic given strong analyst buy ratings (73.92%) and improved financials, but risks include persistent negative cash flows, high debt, and competitive vaccine market pressures. Investment appeal hinges on execution of partnerships and cost management to sustain profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About HSBC Holdings plc
HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.
Read more on HSBC →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
